Flecainide-induced proarrhythmia is attributed to abnormal changes in repolarization and refractoriness in perfused guinea-pig heart

Journal of Cardiovascular Pharmacology

Volumn 60, Issue 5, 2012, Pages 456-466

  Osadchii, Oleg E ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

Author keywords

activation to repolarization coupling; electrical restitution; flecainide; proarrhythmia; refractoriness; repolarization

Indexed keywords

FLECAINIDE;

ACTION POTENTIAL; ARTICLE; CORONARY ARTERY BLOOD FLOW; DRUG INDUCED DISEASE; GUINEA PIG; HEART MUSCLE REFRACTORY PERIOD; HEART PROARRHYTHMIA; HEART REPOLARIZATION; HEART VENTRICLE WALL; MONOMORPHIC VENTRICULAR TACHYCARDIA; NONHUMAN; PRIORITY JOURNAL; QRS COMPLEX;

ANIMALS; ARRHYTHMIAS, CARDIAC; ELECTROCARDIOGRAPHY; ENDOCARDIUM; FEMALE; FLECAINIDE; GUINEA PIGS; MEMBRANE POTENTIALS; PERFUSION; PERICARDIUM; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; VENTRICULAR FUNCTION; VOLTAGE-GATED SODIUM CHANNEL BLOCKERS;

EID: 84870054773     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31826b86cf     Document Type: Article

References (62)

1. Campbell TJ, Vaughan-Williams EM. Voltage-and time-dependent depression of maximum rate of depolarization of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainide. Cardiovasc Res. 1983;17:251-258. (Pubitemid 13096339)
2. Anno T, Hondeghem LM. Interactions of flecainide with guinea-pig cardiac sodium channels. Importance of activation unblocking to the voltage dependence of recovery. Circ Res. 1990;66:789-803. (Pubitemid 20086917)
3. Olsson SB, Edvardsson N. Clinical electrophysiologic study of antiarrhythmic properties of flecainide: acute intraventricular delayed conduction and prolonged repolarization in regular paced and premature beats using intracardiac monophasic action potentials with programmed stimulation. Am Heart J. 1981;102:864-871. (Pubitemid 11027154)
4. Hellestrand KJ, Bexton RS, Nathan AW, et al. Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man. Br Heart J. 1982;48:140-148. (Pubitemid 12093598)
5. Anderson JL, Gilbert EM, Alpert BL, et al. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group. Circulation. 1989;80:1557-1570. (Pubitemid 20031684)
6. Camm J. Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits. Int J Cardiol. 2012;155:362-371.
7. The CAST Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989;321:406-412.
8. Coromilas J, Saltman AE, Waldecker B, et al. Electrophysiological effects of flecainide on anisotropic conduction and reentry in infracted canine hearts. Circulation. 1995;91:2245-2263.
9. Ranger S, Nattel S. Determinants and mechanisms of flecainide-induced promotion of ventricular tachycardia in anesthetized dogs. Circulation. 1995;92:1300-1311.
10. Restivo M, Yin H, Caref EB, et al. Reentrant arrhythmias in the subacute infarction period. The proarrhythmic effect of flecainide acetate on functional re-entrant circuits. Circulation. 1995;91:1236-1246.
11. Falk RH. Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation. Ann Intern Med. 1989;111:107-111. (Pubitemid 19180320)
12. Sihm I, Hansen FA, Rasmussen J, et al. Flecainide acetate in atrial flutter and fibrillation. The arrhythmogenic effects. Eur Heart J. 1990;11:145-148. (Pubitemid 20095699)
13. Fish FA, Gillette PC, Benson DW. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. J Am Coll Cardiol. 1991;18:356-365.
14. Almroth H, Andersson T, Fengsrud E, et al. The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythymic events. J Intern Med. 2011;270:281-290.
15. Rosati B, Grau F, McKinnon D. Regional variation in mRNA transcript abundance within the ventricular wall. J Mol Cell Cardiol. 2006;40:295-302. (Pubitemid 43152385)
16. Remme CA, Verkerk AO, Hoogaars WMH, et al. The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium. Basic Res Cardiol. 2009;104:511-522.
17. Osadchii OE, Soltysinska E, Olesen SP. Na+ channel distribution and electrophysiological heterogeneities in guinea-pig ventricular wall. Am J Physiol Heart Circ Physiol. 2011;300:H989-H1002.
18. Gaborit N, Le Bouter S, Szuts V, et al. Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. J Physiol. 2007;582(pt 2):675-693. (Pubitemid 47040552)
19. Follmer CH, Colatsky TJ. Block of delayed rectifier potassium current, IK, by flecainide and E-4031 in cat ventricular myocytes. Circulation. 1990;82:289-293. (Pubitemid 20216340)
20. Follmer CH, Cullinan CA, Colatsky TJ. Differential block of cardiac delayed rectifier current by class Ic antiarrhythmic drugs: evidence for open channel block and unblock. Cardiovasc Res. 1992;26:1121-1130.
21. Wang DW, Kiyosue T, Sato T, et al. Comparison of the effects of class I antiarrhythmic drugs, cibenzoline, mexiletine and flecainide, on the delayed rectifier K+ current of guinea-pig ventricular myocytes. J Mol Cell Cardiol. 1996;28:893-903. (Pubitemid 26169299)
22. Paul AA, Witchel HJ, Hancox JC. Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine. Br J Pharmacol. 2002;136:717-729. (Pubitemid 34785714)
23. Du CY, El-Harshi A, Zhang YH, et al. Pharmacological inhibition of the hERG potassium channel is modulated by extracellular but not intracellular acidosis. J Cardiovasc Electrophysiol. 2011;22:1163-1170.
24. Brahmajothi MV, Morales MJ, Reimer KA, et al. Regional localization of ERG, the channel protein responsible for the rapid component of the delayed rectifier, K+ current in the ferret heart. Circ Res. 1997;81:128-135. (Pubitemid 27272991)
25. Bryant SM, Wan X, Shipsey SJ, et al. Regional differences in the delayed rectifier current (IKr and IKs) contribute to the differences in action potential duration in basal left ventricular myocytes in guinea-pig. Cardiovasc Res. 1998;40:322-331. (Pubitemid 28506043)
26. Main MC, Bryant SM, Hart G. Regional differences in action potential characteristics and membrane currents of guinea-pig left ventricular myocytes. Exp Physiol. 1998;83:747-761. (Pubitemid 28529001)
27. Cheng J, Kamiya K, Liu W, et al. Heterogeneous distribution of the two components of delayed rectifier K+ current: a potential mechanism of the proarrhythmic effects of methanesulfonanilide class III agents. Cardiovasc Res. 1999;43:135-147. (Pubitemid 29322873)
28. Coker SJ. Drugs for men and women - how important is gender as a risk factor for TdP? Pharmacol Ther. 2008;119:186-194.
29. James AF, Choisy SC, Hancox JC. Recent advances in understanding sex differences in cardiac repolarization. Prog Biophys Mol Biol. 2007;94:265-319. (Pubitemid 46766581)
30. Gibbs M, Veliotes DG, Anamourlis C, et al. Chronic beta-adrenoreceptor activation increases cardiac cavity size through chamber remodeling and not via modifications in myocardial material properties. Am J Physiol Heart Circ Physiol. 2004;287:H2762-2767. (Pubitemid 39557150)
31. Osadchii OE, Larsen AP, Olesen SP. Predictive value of electrical restitution in hypokalemia-induced ventricular arrhythmogenicity. Am J Physiol Heart Circ Physiol. 2010;298:H210-H220.
32. Osadchii OE. Effects of ventricular pacing protocol on electrical restitution assessments in guinea-pig heart. Exp Physiol. 2012;97:807-821.
33. Soltysinska E, Olesen SP, Osadchii OE. Myocardial structural, contractile and electrophysiological changes in the guinea-pig heart failure model induced by chronic sympathetic activation. Exp Physiol. 2011;96:647-663.
34. Osadchii OE, Woodiwiss AJ, Norton G. Contractile responses to selective phosphodiesterase inhibitors following chronic beta-adrenoreceptor activation. Pflugers Arch. 2006;452:155-163. (Pubitemid 44029840)
35. Hodges M, Haugland JM, Granrud G, et al. Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent. Circulation. 1982;65:879-885. (Pubitemid 12081311)
36. Dhein S, Muller A, Gerwin R, et al. Comparative study on the proarrhythmic effects of some antiarrhythmic agents. Circulation. 1993;87:617-630. (Pubitemid 23040932)
37. Fagbemi SO, Chi L, Lucchesi BR. Antifibrillatory and profibrillatory actions of selected class I antiarrhythmic agents. J Cardiovasc Pharmacol. 1993;21:709-719. (Pubitemid 23121867)
38. Katritsis D, Rowland E, O'Nunain S, et al. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms. Eur Heart J. 1995;16:1930-1935.
39. Sarubbi B, Ducceschi V, Briglia N, et al. Compared effects of sotalol, flecainide and propafenone on ventricular repolarization in patients free of underlying structural heart disease. Int J Cardiol. 1998;66:157-164. (Pubitemid 29052341)
40. Lim KS, Jang IJ, Kim BH, et al. Changes in the QTc interval after administration of flecainide acetate, with and without co-administered paroxetine, in relation to cytochrome P450 2D6 genotype: data from an open-label, two-period, single-sequence crossover study in healthy Korean male subjects. Clin Ther. 2010;32:659-666.
41. Kim HS, Pak HN, Park JS, et al. Flecainide-associated bradycardiadependent torsade de pointes: another potential mechanism of proarrhythmia. Pacing Clin Electrophysiol. 2010:1-3. Published online ahead of print. [DOI: 10.1111/j.1540-8159.2010.02935.x].
42. Ohki R, Takahashi M, Mizuno O, et al. Torsades de pointes ventricular tachycardia induced by mosapride and flecainide in the presence of hypokalemia. Pacing Clin Electrophysiol. 2001;24:119-121. (Pubitemid 32165740)
43. Lehtonen A, Fodstad H, Laitinen-Forsblom P, et al. Further evidence of inherited long QT syndrome gene mutations in antiarrhythmic drug-associated torsades de pointes. Heart Rhythm. 2007;4:603-607. (Pubitemid 46655584)
44. Franz MR. Mechano-electrical feedback in ventricular myocardium. Cardiovasc Res. 1996;32:15-24. (Pubitemid 26232649)
45. Hardziyenka M, Campian ME, Bouma BJ, et al. Right-to-left ventricular diastolic delay in chronic thromboembolic pulmonary hypertension is associated with activation delay and action potential prolongation in right ventricle. Circ Arrhythm Electrophysiol. 2009;2:555-561.
46. Laurita KR, Girouard SD, Rosenbaum DS. Modulation of ventricular repolarization by a premature stimulus. Role of epicardial dispersion of repolarization kinetics demonstrated by optical mapping of the intact guinea-pig heart. Circ Res. 1996;79:493-503. (Pubitemid 26276909)
47. Mantravadi R, Gabris B, Liu T, et al. Autonomic nerve stimulation reverses ventricular repolarization sequence in rabbit hearts. Circ Res. 2007;100:e72-e80. (Pubitemid 46598935)
48. Azarov JE, Shmakov DN, Vityazev VA, et al. Ventricular repolarization pattern under heart cooling in the rabbit. Acta Physiol (Oxf). 2008;193:129-138. (Pubitemid 351661596)
49. Gepstein L, Hayam G, Ben-Haim SA. Activation-repolarization coupling in the normal swine endocardium. Circulation. 1997;96:4036-4043.
50. Yue AM, Betts TR, Roberts PR, et al. Global dynamic coupling of activation and repolarization in the human ventricle. Circulation. 2005;112:2592-2601. (Pubitemid 41532595)
51. Warren M, Guha PK, Berenfeld O, et al. Blockade of the inward rectifying potassium current terminates ventricular fibrillation in the guineapig heart. J Cardiovasc Electrophysiol. 2003;14:621-631. (Pubitemid 36733543)
52. Poelzing S, Veeraraghavan R. Heterogeneous ventricular chamber response to hypokalemia and inward rectifier potassium channel blockade underlies bifurcated T wave in guinea-pig. Am J Physiol Heart Circ Physiol. 2007;292:H3043-H3051. (Pubitemid 47084558)
53. Pandit SV, Kaur K, Zlochiver S, et al. Left-to-right ventricular differences in IKATP underlie epicardial repolarization gradient during global ischemia. Heart Rhythm. 2011;8:1732-1739.
54. Ramanathan C, Jia P, Ghanem R, et al. Activation and repolarization of the normal human heart under complete physiological conditions. Proc Natl Acad Sci U S A. 2006;103:6309-6314.
55. Verduyn SC, Vos MA, van der Zande J, et al. Role of interventricular dispersion of repolarization in acquired torsade-de-pointes arrhythmias: reversal by magnesium. Cardiovasc Res. 1997;34:453-463. (Pubitemid 27272664)
56. Smith RM, Velamakanni SS, Tolkacheva EG. Interventricular heterogeneity as a substrate for arrhythmogenesis of decoupled mitochondria during ischemia in the whole heart. Am J Physiol Heart Circ Physiol. 2012;303:H224-H233.
57. Osadchii OE, Olesen SP. Electrophysiological determinants of hypokalemia-induced arrhythmogenicity in the guinea-pig heart. Acta Physiol (Oxf). 2009;197:273-287.
58. Selvaraj RJ, Suszko AM, Subramanian A, et al. Adrenergic stimulation increases repolarization dispersion and reduces activation-repolarization coupling along the RV endocardium of patients with cardiomyopathy. Europace. 2009;11:1529-1535.
59. Subramanian A, Suszko A, Selvaraj RJ, et al. Modulated dispersion of activation and repolarization by premature beats in patients with cardiomyopathy at risk of sudden death. Am J Physiol Heart Circ Physiol. 2011;300:H2221-H2229.
60. Weiss JN, Garfinkel A, Karaguezian HS, et al. Chaos and the transition to ventricular fibrillation. A new approach to antiarrhythmic drug evaluation. Circulation. 1999;99:2819-2826. (Pubitemid 29250030)
61. Krishnan SC, Antzelevitch C. Flecainide-induced arrhythmia in canine ventricular epicardium. Phase 2 re-entry? Circulation. 1993;87:562-572. (Pubitemid 23040926)
62. Zicha S, Moss I, Allen B, et al. Molecular basis of species-specific expression of repolarizing K+ currents in the heart. Am J Physiol Heart Circ Physiol. 2003;285:H1641-H1649. (Pubitemid 37169520)